Skip to main content
. 2020 May 20;34(1):102–111. doi: 10.1007/s12028-020-00986-4

Fig. 3.

Fig. 3

Potential adverse drug effects during neurostimulant administration. Potential adverse drug effects were identified by reviewing provider progress notes, the medication administration record, electrocardiograms, and nursing flow sheets. Causality assessments were not conducted due to the presence of confounding variables in this patient population. *QTc prolongation was only assessed in patients receiving amantadine